NeoGenomics Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- NeoGenomics Laboratories's estimated annual revenue is currently $579.1M per year.
- NeoGenomics Laboratories received $150.0M in venture funding in December 2016.
- NeoGenomics Laboratories's estimated revenue per employee is $386,100
- NeoGenomics Laboratories's total funding is $350.5M.
Employee Data
- NeoGenomics Laboratories has 1500 Employees.
- NeoGenomics Laboratories grew their employee count by 10% last year.
NeoGenomics Laboratories's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Sr. VP Sales Precision Medicine | Reveal Email/Phone |
3 | Chief Compliance Officer | Reveal Email/Phone |
4 | CFO | Reveal Email/Phone |
5 | Chief Architect | Reveal Email/Phone |
6 | VP - Pharma IT (Head) | Reveal Email/Phone |
7 | VP - Pharma Services Molecular Operations | Reveal Email/Phone |
8 | EVP for Research & Development and CSO | Reveal Email/Phone |
9 | VP - Data Strategy and Analytics | Reveal Email/Phone |
10 | Head Product Management | Reveal Email/Phone |
NeoGenomics Laboratories Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $127.6M | 378 | 12% | N/A | N/A |
#2 | $77.8M | 262 | 5% | N/A | N/A |
#3 | $21.9M | 81 | 21% | N/A | N/A |
#4 | $66.5M | 224 | -3% | N/A | N/A |
#5 | $271.8M | 719 | 8% | N/A | N/A |
#6 | $60.3M | 203 | 21% | N/A | N/A |
#7 | $110.7M | 328 | N/A | N/A | N/A |
#8 | $197.1M | 584 | 6% | N/A | N/A |
#9 | $290.3M | 768 | 6% | N/A | N/A |
#10 | $34.8M | 129 | 7% | N/A | N/A |
What Is NeoGenomics Laboratories?
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more. CONNECT WITH US Online: neogenomics.com Twitter: https://twitter.com/NeoGenomics Facebook: facebook.com/neogenomics
keywords:Biotechnology,Healthcare,Healthcare Providers,Medical Diagnostics,Pharmaceuticals
$350.5M
Total Funding
1500
Number of Employees
$579.1M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NeoGenomics Laboratories News
said Lynn Tetrault, Executive Chair of NeoGenomics. ... CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida;...
The operator of cancer-focused testing laboratories posted revenue of $117.2 million in the period, also exceeding Street forecasts.
This partnership strengthens NeoGenomics' proteomics-based product ... Pharma Services, NeoGenomics Laboratories, Inc. "Partnering with...
Other Companies in Fort Myers
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $300M | 1665 | 3% | N/A |
#2 | $716.6M | 2255 | 1% | N/A |
#3 | $614.4M | 2438 | N/A | N/A |
#4 | $1151.7M | 3624 | 2% | N/A |
#5 | $1698M | 6738 | 3% | N/A |
NeoGenomics Laboratories Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2003-04-16 | $1.5M | Debt Financing | Medical Venture Partners | Article |
| 2005-03-30 | $1.5M | Undisclosed | Aspen Select Healthcare LP | Article |
| 2006-01-26 | $0.6M | Undisclosed | Article | |
| 2007-06-08 | $8.0M | Undisclosed | Wachovia Bank | Article |
| 2013-03-01 | $9.5M | Undisclosed | Craig-Hallum Capital Group LLC | Article |
| 2014-08-25 | $34.6M | Undisclosed | William Blair & Company, L.L.C. | Article |
| 2016-12-23 | $150.0M | Undisclosed | Article |